ClinicalTrials.govpublic full text
Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease
patients with type 2 diabetes
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 329471
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.